The Chemours Company

Total Valuation

The Chemours Company carries a market capitalization of 3.40B, placing it among publicly traded companies globally. Its enterprise value stands at 7.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

The Chemours Company currently has 150.36M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 0.57, and the price-to-book ratio stands at 2.81.

Enterprise Valuation

On an enterprise value basis, The Chemours Company trades at an EV/EBITDA multiple of 26.36 and an EV/FCF ratio of 8.08. The EV/Sales ratio of 1.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 171.82 provides insight into valuation relative to core operating earnings.

Financial Position

The Chemours Company maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2,032.87, indicating elevated leverage, while an interest coverage ratio of 1.00 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

The Chemours Company's stock has gained approximately 127.69386% over the past 52 weeks. The 50-day moving average sits at 23.25, while the 200-day moving average is 17.03.

Income Statement

Over the trailing twelve months, The Chemours Company generated 5.82B in revenue and converted that into -411.00M in net income, yielding earnings per share of -2.72. EBITDA reached 271.00M, while operating income came in at -60.00M.

Balance Sheet

The Chemours Company holds 563.00M in cash and equivalents against 4.39B in total debt, resulting in a net debt position of 3.57B. Total book value stands at 1.18B, with working capital of 1.32B providing operational flexibility.

Cash Flow

The Chemours Company produced 332.00M in operating cash flow over the past twelve months. After subtracting -178.00M in capital expenditures, free cash flow totaled 154.00M - equivalent to 1.02 per share.

Margins

The Chemours Company operates with a gross margin of 15.10, reflecting its pricing power and cost economics. The operating margin of -1.03 and net profit margin of -7.06 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of -13.14 indicates the proportion of earnings distributed to shareholders.

Scores

The Chemours Company posts an Altman Z-Score of 1.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.